ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

STUDY TO KNOW THE INTRAVENOUS OCTEROTIDE EFFICACY FOR THE MANAGEMENT OF EARLY VARICEAL BLEEDING AFTER SCLEROTHERAPY

Dr. Imran Akram, Dr. Muhammad Ali Zaman, Dr. Muhammad Saqib Ali Farooq

Objective: The aim of this study was to evaluate the efficacy of intravenous octreotide after sclerotherapy in the prevention of variceal bleeding. Study Design: A comparative / interventional study. Place and Duration: In the Gastroenterology Department Jinnah Hospital Lahore for one year duration from June 2017 to June 2018. Methods: Sixty consecutive patients (mean age: 47.48 ± 9.60 years) (26-65 years) with acute variceal bleeding were included in the study. There were Forty-two (70%) males and eighteen (30%) females. They were randomized into two equal groups. In the study group (group I), 24 hours after sclerotherapy, octreotide infusion (25 g / hour) was continued, while the control group received approximately the same amount of saline. Both groups were observed for the presence of early re-bleeding of varices for five days after sclerotherapy. Results: Re-bleeding was 23.3% in group I and 33.3% in group II (p> 0.05). The number of patients requiring blood transfusion was similar in both groups (p> 0.05). According to a general impression at the end of the study, 10% of the patients became unstable in group I and 36.7% in group II became unstable (p = 0.02). . Conclusion: After 24 hours of sclerotherapy, no significant effect was observed for the prevention of re-bleeding with the variants of octreotide infusion. However, at the end of the study, a general impression based on hemodynamic status revealed that patients were clinically more stable after an injection of octreotide after an injection sclerotherapy. Key words: sclerotherapy, variceal re-bleeding

FULL TEXT